{"schema_version":"secwatch.filing_event.v1","accession":"0001773751-24-000130","form_type":"8-K","ticker":"HIMS","cik":"0001773751","company_name":"Hims & Hers Health, Inc.","filed_at":"2024-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.008515+00:00","generated_at":"2026-06-02T22:17:22.308748+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Hims & Hers Q1 2024 revenue $278.2M (+46% YoY), net income $11.1M, raises FY guidance","bullets":["Revenue $278.2M, up 46% YoY; net income $11.1M vs loss of $10.1M a year ago.","Subscribers reached 1.7M, up 41% YoY, with a record 172k net additions.","Adjusted EBITDA $32.3M, up 434% YoY from $6.1M; gross margin improved to 82%.","FY2024 revenue guidance raised to $1.20-1.23B, Adjusted EBITDA to $120-135M, exceeding prior 2025 targets.","Over 35% of subscribers now on personalized solutions; marketing spend leverage improving."],"urls":{"canonical":"https://secwatch.observer/filing/0001773751-24-000130","json":"https://secwatch.observer/filing/0001773751-24-000130.json","markdown":"https://secwatch.observer/filing/0001773751-24-000130.md","text":"https://secwatch.observer/filing/0001773751-24-000130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1773751/000177375124000130/0001773751-24-000130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1773751/000177375124000130/hims-20240506.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T22:17:22.308748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"31140e1846ad86ff79bd388f2905882a492e968e","claim":"Hims & Hers Health, Inc. reported the first quarter ended March 31, 2024 results: revenue Revenue of $278.2 million, net income Net income of $11.1 million. Guidance raised.","evidence_excerpt":"be expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results Revenue of $278.2 million, up 46% year-over-year in 2024 Net income of $11.1 million; Adjusted EBITDA of $32.3 million in Q1 2024 Subscribers grew to 1.7 million, up 41% year-over-year in Q1 2024 Raises","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1773751/000177375124000130/0001773751-24-000130-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Revenue","value":"Revenue of $278.2 million"},{"label":"Net income","value":"Net income of $11.1 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}